Atlas Trials

Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Clinical trial NCT01162746 · COMPLETED

Trial details

NCT number
NCT01162746
Sponsor
Medical University of Vienna
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Age-Related Macular DegenerationNeovascularization, Choroidal
Start date
2011-10-01
Primary completion
2015-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.